Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen D Smith

Showing results (151-160 of 159) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 159 results.
Blood Advances|March 12, 2021
Autologous stem cell transplantation after anti-PD-1 therapy for multiply relapsed or refractory Hodgkin lymphomaReid W Merryman, Robert A Redd, Taiga Nishihori, et al.
Blood Advances|May 12, 2023
High-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective studyAdam S Zayac, Daniel J Landsburg, Mitchell E Hughes, et al.
Blood|July 15, 2025
Real-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamabTaylor R Brooks, Emily C Zabor, Yohanna Bedelu, et al.
Multisensory Research|December 10, 2024
Research Priorities for Autonomous Sensory Meridian Response: An Interdisciplinary Delphi StudyThomas J Hostler, Giulia L Poerio, Clau Nader, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2021
Burkitt Lymphoma International Prognostic IndexAdam J Olszewski, Lasse H Jakobsen, Graham P Collins, et al.
Blood Advances|July 20, 2021
HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysisJuan Pablo Alderuccio, Adam J Olszewski, Andrew M Evens, et al.
Haematologica|February 4, 2021
Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort studyAdam S Zayac, Andrew M Evens, Alexey Danilov, et al.
Blood|July 15, 2020
Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centersAndrew M Evens, Alexey Danilov, Deepa Jagadeesh, et al.
Leukemia|March 4, 2021
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphomaReid W Merryman, Luca Castagna, Laura Giordano, et al.
Pageof 16

Showing results (151-160 of 159) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 159 results.
Blood Advances|March 12, 2021
Autologous stem cell transplantation after anti-PD-1 therapy for multiply relapsed or refractory Hodgkin lymphomaReid W Merryman, Robert A Redd, Taiga Nishihori, et al.
Blood Advances|May 12, 2023
High-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective studyAdam S Zayac, Daniel J Landsburg, Mitchell E Hughes, et al.
Blood|July 15, 2025
Real-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamabTaylor R Brooks, Emily C Zabor, Yohanna Bedelu, et al.
Multisensory Research|December 10, 2024
Research Priorities for Autonomous Sensory Meridian Response: An Interdisciplinary Delphi StudyThomas J Hostler, Giulia L Poerio, Clau Nader, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2021
Burkitt Lymphoma International Prognostic IndexAdam J Olszewski, Lasse H Jakobsen, Graham P Collins, et al.
Blood Advances|July 20, 2021
HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysisJuan Pablo Alderuccio, Adam J Olszewski, Andrew M Evens, et al.
Haematologica|February 4, 2021
Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort studyAdam S Zayac, Andrew M Evens, Alexey Danilov, et al.
Blood|July 15, 2020
Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centersAndrew M Evens, Alexey Danilov, Deepa Jagadeesh, et al.
Leukemia|March 4, 2021
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphomaReid W Merryman, Luca Castagna, Laura Giordano, et al.
Pageof 16